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Type 2 diabetes mellitus (T2DM) has recently been recognized as a significant risk
factor for bone fragility. Careful investigations of bone mechanical properties in
human studies suggested possible alterations of bone composition, although this axis
has poorly been investigated. The main aim of this study was to evaluate the impact of
high fat diet-induced diabetes and therapy using the clinically approved GLP-1
receptor agonist, exenatide, on tissue bone mechanical properties and compositional
parameters. Male mice had free access to high fat diet for 16 weeks to induce
diabetes prior to commencement of the study. Exenatide was administered twice daily
by i.p. injection at a dose of 25 nmol/kg for 52 days. Normal and high fat diet fed
(HFD) mice injected with saline were used as controls. Bone mechanical properties
was assessed at the organ level by 3-point bending and at the tissue level by
nanoindentation. Bone microarchitecture was investigated by microcomputed
tomography and bone composition was evaluated by Fourier transform infrared
imaging. HFD mice exhibited profound alterations of bone mechanical properties at
both the organ and tissue level. Collagen maturity as well as trabecular and cortical
bone microarchitectures were abnormal. Administration of exenatide, led to clear
ameliorations in bone mechanical properties at the organ and tissue levels by
modifications of both cortical microarchitecture and bone compositional parameters
(collagen maturity, mineral crystallinity, carbonate/phosphate ratio, acid phosphate
content). These results bring new light on the mode of action of exenatide in bone
physiology and demonstrate the value of GLP-1 mimetics in the treatment of fragility
fractures in diabetes.
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